“Miracle drugs” swarm on social networks in the Dominican Republic, Public Health wants to control it
Santo Domingo.- The sale of uncertified medicines through social media platforms without any medical endorsement is a growing concern for health authorities in the Dominican Republic. Minister of Public Health, Daniel Rivera, raised the alarm about these “miracle drugs” being promoted without scientific backing, often using influencers or false advertising to attract buyers.
Many of these products are being advertised on social networks, claiming numerous benefits and even employing popular figures and influencers to entice consumers. People often fall victim to scams when purchasing these products. Rivera stressed the need for increased controls and intervention to address this issue, while also urging the public to remain vigilant and ensure that the products they buy or consume have proper regulation and certification.
Rivera cited an example from last year when his own image was used without consent to endorse blood pressure products, a situation he promptly denounced. The responsibility of verifying the regulation and certification of medicines, as well as suspending and removing counterfeit or expired products, falls under the General Directorate of Medicines, Food, and Health Products of the Ministry of Public Health (Digemaps).
The Minister encouraged the public to ensure that health products and services they consume or purchase have the proper regulation, certification, or authorization issued by the Ministry of Public Health to guarantee their quality. He further revealed that 137 centers have been shut down this year for non-compliance with licensing regulations.
The Dominican Republic recently hosted the “Congress of Central American Drug Regulatory Agencies,” where 12 Latin American nations aimed to strengthen controls in the marketing of consumer products. The participating countries, including Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, and Panama, sought to establish common regulations and controls at the regional level. The Pan American Health Organization (PAHO) reiterated its commitment to providing technical cooperation requested by member states to strengthen drug regulatory authorities in Central America and the Dominican Republic.